CLOV - NASDAQ
Clover Health Investments, Corp.
$3.96
+8.6%Clover Health Investments, Corp. operates as a medicare advantage insurer in the United States. The company through its Clover Assistant, a software platform that provides preferred provider organization and health maintenance organization health plans for medicare-eligible consumers. It also focuses on non-insurance businesses. Clover Health Investments, Corp. was incorporated in 2014 and is based in Franklin, Tennessee.
At a Glance
Live SnapshotClover Health Investments, Corp. Cash Conversion Engine
Cash Flow Quality Analysis
FCF Conversion Rate
Strong cash conversion. Most reported earnings translate into actual cash flow, suggesting solid fundamentals.
CapEx Intensity
Asset-light business model. Low capital requirements leave more cash available for shareholders and growth investments.
FCF Growth Trend
Significant FCF decline raises concerns. Urgent review needed of operational performance and capital allocation.
Working Capital Impact
Significant working capital drain. Growth may be consuming cash through inventory buildup or receivables extension—monitor closely.
Cash Flow Quality Insight
Working capital strain: Significant cash tied up in operations. Monitor receivables collection, inventory turns, and payment terms to optimize cash conversion cycle.
Clover Health Investments, Corp. Cash Flow Statement
CLOV • NASDAQ
| Clover Health Investments, Corp. Cash Flow Statement | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 |
|---|---|---|---|---|---|---|---|---|
OPERATING ACTIVITIES | ||||||||
-85.5M | -43M | -213.4M | -339.6M | -587.8M | -136.4M | -363.7M | -201.9M | |
1.7M | 1.3M | 2.5M | 1.2M | 1.2M | 0.0 | 551K | 487K | |
0.0 | 0.0 | 0.0 | 0.0 | -66.1M | 0.0 | 0.0 | 0.0 | |
103.7M | 114.3M | 140.9M | 164.3M | 163.7M | 0.0 | 3.3M | 3.7M | |
-2.5M | -50.7M | 9.5M | -27.5M | 13.9M | 42.4M | 167.7M | 9.5M | |
-84.2M | 12.9M | -55.4M | -2.4M | 192.7M | -24.5M | 32.3M | 35M | |
-66.9M | 34.8M | -115.9M | -203.9M | -282.3M | -118.5M | -159.9M | -153.3M | |
INVESTING ACTIVITIES | ||||||||
-2M | -1.6M | -584K | -4.5M | -723K | -693K | -23K | -1.5M | |
(0.0) | (0.0) | (0.0) | -16.2M | (434.7M) | (3.9M) | -1.2M | (0.0) | |
-205.1M | -201.2M | -175.6M | -369.6M | -876.3M | -174.3M | -505.5M | (0.0) | |
211.2M | 203.4M | 316.2M | 485.4M | 441.5M | 312.4M | 324.8M | 0.0 | |
0.0 | 0.0 | 0.0 | 0.0 | -434.7M | 0.0 | 0.0 | 99M | |
(4.1M) | (565K) | (140M) | (95.1M) | -435.4M | (141.3M) | -181.9M | (97.5M) | |
FINANCING ACTIVITIES | ||||||||
-53.4M | -17.4M | -5.1M | -5M | 289.8M | 1.7M | 601K | 0.0 | |
0.0 | 0.0 | 0.0 | 0.0 | -30.9M | 1.2M | 333.7M | 29.8M | |
-55.2M | -18.3M | -6.2M | -6.4M | -147K | (0.0) | (0.0) | (0.0) | |
0.0 | 0.0 | -28.8M | 0.0 | 666.5M | -957K | -363K | 44.8M | |
-53.4M | -17.4M | -33.9M | -5M | 925.4M | 1.9M | 334M | 74.6M | |
CASH FLOW SUMMARY | ||||||||
0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 67.6M | 0.0 | 0.0 | |
-116.2M | 18M | -9.7M | -113.8M | 207.6M | 92.3M | -7.8M | 18.8M | |
194.5M | 176.5M | 186.2M | 300M | 92.3M | 0.0 | 75.4M | 56.6M | |
78.3M | 194.5M | 176.5M | 186.2M | 300M | 92.3M | 67.6M | 75.4M | |
-69M | 33.3M | -116.5M | -208.4M | -283M | -119.2M | -159.9M | -154.8M |
SEC Filings
CLOV - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
8-K 8-K 2026 N/A | May 18, 2026 | May 18, 2026 | 2026 | |
10-Q 10-Q 2026 Q1 Q1 | May 08, 2026 | March 31, 2026 | 2026 | |
8-K 8-K 2026 N/A | May 06, 2026 | May 06, 2026 | 2026 | |
DEF 14A DEF 14A 2026 N/A | April 28, 2026 | April 28, 2026 | 2026 | |
8-K 8-K 2026 N/A | April 01, 2026 | March 30, 2026 | 2026 | |
8-K/A 8-K/A 2026 (Amended) N/A | March 06, 2026 | March 06, 2026 | 2026 | |
8-K 8-K 2026 N/A | March 06, 2026 | March 06, 2026 | 2026 | |
10-K 10-K 2025 FY FY | February 27, 2026 | December 31, 2025 | 2025 | |
8-K 8-K 2026 N/A | February 26, 2026 | February 26, 2026 | 2026 | |
8-K 8-K 2026 N/A | January 14, 2026 | January 14, 2026 | 2026 |
Related Guides
Continue your CLOV research with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.